Vir Biotechnology, Inc. Financial Ratios — VIR Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-52.36	49.2	29.39	-33.53	-38.09	-45.73
Return on Assets (%)	- -	-52.3	-49.65	-41.75	36.8	21.69	-26.06	-31.46	-36.47
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	34.24	30.01	- -	- -	- -
Gross Margin (%)	100	100	100	100	93.94	90.74	93	98.67	99.96
EBITDA Margin (%)	-54,406.04	-13,356.68	-24,396.91	-433.55	39.24	53.14	-1,649.1	-843.81	-703.29
Operating Margin (%)	-54,695.97	-13,674.19	-25,032.21	-441.64	38.71	52.71	-1,698.35	-866.67	-720.85
Incremental Operating Margin (%)	- -	- -	- -	- -	70.38	83.57	- -	- -	- -
Pretax Margin (%)	-54,212.08	-13,405.99	-24,546.98	-444.06	50.58	47.72	-1,590.61	-821.05	-658.1
Profit Margin (%)	-46,880.54	-13,350.69	-24,568.64	-444.14	48.62	32.64	-1,557.35	-819.25	-658.43
Net Income to Common Margin (%)	-46,880.54	-13,339.75	-24,568.64	-444.14	48.62	32.64	-1,557.35	-819.25	-658.43
Effective Tax Rate (%)	- -	- -	- -	- -	3.86	31.61	- -	- -	- -
Dvd Payout Ratio (%)	- -	-0.08	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-52.36	49.2	29.39	-33.53	-38.09	-45.73

Credit (USD)

Credit Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	70	137	128	125	98	98
ST Debt	- -	- -	- -	4	4	4	13	8	9
LT Debt	- -	- -	- -	67	134	124	112	90	89
Total Debt/EBITDA	- -	- -	- -	-0.24	0.32	0.15	-0.19	-0.18	-0.21
Net Debt/EBITDA	2.32	0.41	0.63	1.5	-0.82	-1.01	0.37	0.41	0.5
Total Debt/EBIT	- -	- -	- -	-0.24	0.33	0.15	-0.19	-0.18	-0.2
Net Debt/EBIT	2.31	0.4	0.61	1.47	-0.83	-1.02	0.36	0.4	0.48
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-27.39	-93.52	82.79	78.02	73.27	74.16	82.87	82.24	76.31
Long-Term Debt/Equity (%)	- -	- -	- -	9.28	9.33	5.96	7.02	7.84	11.64
Long-Term Debt/Capital (%)	- -	- -	- -	8.46	8.51	5.61	6.51	7.22	10.32
Long-Term Debt/Total Assets (%)	- -	- -	- -	7.24	6.83	4.42	5.82	6.44	8.88
Total Debt/Equity (%)	- -	- -	0.06	9.79	9.6	6.16	7.83	8.51	12.79
Total Debt/Capital (%)	- -	- -	0.06	8.92	8.76	5.8	7.26	7.84	11.34
Total Debt/Total Assets (%)	- -	- -	0.05	7.64	7.04	4.57	6.49	7	9.76
Net Debt to Equity	272.68	26.56	-25.79	-60.9	-24.29	-40.84	-15.19	-19.38	-30.34
Net Debt/Capital (%)	73.17	20.99	-34.73	-124.57	-28.47	-62.52	-16.4	-21.74	-36.8
EBITDA	-81	-116	-173	-292	427	840	-651	-538	-468
EBITDA-CapEx	-84	-124	-182	-298	405	772	-673	-545	-473
Operating Income (Loss)	-81	-119	-178	-297	421	833	-671	-552	-480

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	15.11	2.47	6.48	7.44	2.08	4.7	8.68	7.57	5.03
Current Ratio	15.46	2.95	6.81	7.8	4.58	4.93	9.05	8.71	5.54
Quick Ratio	15.11	2.47	6.48	7.44	4.34	4.7	8.68	7.57	5.03
CFO/Avg Current Liab	- -	-3.6	-2.62	-2.41	-0.22	3.9	-2.27	-3.03	-3.69
Common Equity/Total Assets	-27.39	-93.52	82.79	78.02	73.27	74.16	82.87	82.24	76.31
Long-Term Debt/Equity (%)	- -	- -	- -	9.28	9.33	5.96	7.02	7.84	11.64
Long-Term Debt/Capital (%)	- -	- -	- -	8.46	8.51	5.61	6.51	7.22	10.32
Long-Term Debt/Total Assets (%)	- -	- -	- -	7.24	6.83	4.42	5.82	6.44	8.88
Total Debt/Equity (%)	- -	- -	0.06	9.79	9.6	6.16	7.83	8.51	12.79
Total Debt/Capital (%)	- -	- -	0.06	8.92	8.76	5.8	7.26	7.84	11.34
Total Debt/Total Assets (%)	- -	- -	0.05	7.64	7.04	4.57	6.49	7	9.76
CFO/Total Liabilities	-20.71	-25.38	-147.09	-94.57	-9.11	229.69	-236.84	-179.67	-164.93
CFO/CapEx	-24.21	-11.49	-14.5	-29.16	-2.18	24.46	-36.1	-61.14	-81.08
Altman's Z-Score	-0.82	-4.13	7.72	8.94	8.28	5.43	2.04	1.18	-0.62

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	11.36	22.61	0.43	0.15	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	32.14	16.14	841.94	2,465.37	104,474.23
Cash Conversion Cycle	- -	- -	- -	- -	-32.14	-16.14	-841.94	-2,465.37	-104,474.23
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	1,354	3,412	5,492	3,372	1,356	1,005	841
- Cash & Cash Equivalents	188	48	109	437	348	849	242	223	232
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	70	137	128	125	98	98
Enterprise Value	-188	-98	971	2,746	4,921	1,098	-42	198	472
Total Capital	-69	-179	424	787	1,569	2,206	1,715	1,248	863
Total Debt/Capital (%)	- -	- -	0.06	8.92	8.76	5.8	7.26	7.84	11.34
Total Debt / EV	- -	- -	- -	0.03	0.03	0.12	-2.97	0.49	0.21
EV/Sales	- -	- -	1,365.72	40.83	4.53	0.69	- -	3.1	7.09
EV/EBITDA	- -	- -	- -	- -	11.54	1.31	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	11.7	1.32	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	0.66	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	0.63	- -	- -	- -
Diluted Market Cap	- -	- -	382	3,191	5,587	3,412	1,349	1,000	835
Diluted Enterprise Value	-188	-48	273	2,825	5,377	2,691	1,232	875	701
EV per Share	- -	- -	9.02	21.55	37.52	8.24	- -	1.44	3.38
TTM Sales	- -	1	1	67	1,087	1,580	39	64	67
TTM EBITDA	-81	-116	-173	-292	427	840	-651	-538	-468
TTM Operating Income	-81	-119	-178	-297	421	833	-671	-552	-480
TTM Cash Flow to Firm	-66	-94	-130	-191	-48	1,663	-779	-446	-392
TTM Free Cash Flow to Firm	-64	-86	-121	-184	-26	1,731	-757	-439	-387

Multiples (USD)

Valuation Multiples API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-3.16	-17.31	-216.79	1.97	-1.78	-2.28	-2.16
EV/EBIT	- -	- -	- -	- -	11.7	1.32	- -	- -	- -
Enterprise Value	-188	-98	971	2,746	4,921	1,098	-42	198	472
Low Price	- -	- -	11.65	12	25.31	18.05	7.72	6.56	4.16
EV/Sales	- -	- -	1,365.72	40.83	4.53	0.69	- -	3.1	7.09
EV/EBITDA	- -	- -	- -	- -	11.54	1.31	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	10.29	6.51	- -	- -	- -
Price/Earnings Average	- -	- -	-2.33	-13.59	11.15	6.61	-4.03	-2.37	-1.99
Price/Earnings High	- -	- -	-2.87	-29.92	34.65	10.76	-6.88	-3.42	-4.57
Price/Earnings Low	- -	- -	-2.02	-4.79	6.22	4.64	-1.68	-1.71	-1.32
Price/Book Value	- -	- -	3.19	4.76	3.84	1.62	0.85	0.87	1.1
Price/Book Value Average	- -	- -	3.4	6.05	4.15	1.65	1.57	1.08	1.15
Price/Book Value High	- -	- -	4.19	13.33	12.92	2.68	2.67	1.56	2.63
Price/Book Value Low	- -	- -	2.96	2.13	2.32	1.16	0.65	0.78	0.76
Price/Tangible Book Value	- -	- -	3.65	5.12	3.97	1.66	0.87	0.89	1.14
Price/Tangible Book Value Average	- -	- -	3.88	6.51	4.31	1.69	1.61	1.1	1.19
Price/Tangible Book Value High	- -	- -	4.78	14.35	13.39	2.75	2.74	1.59	2.72
Price/Tangible Book Value Low	- -	- -	3.38	2.3	2.4	1.19	0.67	0.8	0.78
Price/Sales	- -	- -	536.99	47.45	5	2.12	34.17	15.7	12.56
Price/Sales Average	- -	- -	571.85	60.35	5.42	2.16	62.72	19.4	13.11
Price/Sales High	- -	- -	704.32	132.9	16.85	3.51	107.15	27.99	30.09
Price/Sales Low	- -	- -	497.29	21.26	3.02	1.51	26.22	14.03	8.66
Price/Cash Flow	- -	- -	-2.95	-16.71	-114.28	2.02	-1.73	-2.24	-2.13
Price/Cash Flow Average	- -	- -	-3.14	-21.25	-123.79	2.05	-3.18	-2.77	-2.23
Price/Cash Flow High	- -	- -	-3.86	-46.8	-384.86	3.34	-5.43	-4	-5.11
Price/Cash Flow Low	- -	- -	-2.73	-7.49	-69.08	1.44	-1.33	-2	-1.47
Price/Free Cash Flow Average	- -	- -	-3.37	-22.01	-234.84	2	-3.27	-2.82	-2.25
Price/Free Cash Flow High	- -	- -	-4.15	-48.47	-730.09	3.26	-5.59	-4.06	-5.17
Price/Free Cash Flow Low	- -	- -	-2.93	-7.75	-131.05	1.41	-1.37	-2.04	-1.49
EV/Sales Average	- -	- -	1,874.87	59.08	5.28	1.71	60.06	17.54	11.18
EV/Sales High	- -	- -	2,344.74	136.66	16.82	3.07	104.71	26.18	28.28
EV/Sales Low	- -	- -	1,610.42	17.29	2.86	1.07	23.38	12.14	6.7
EV/EBITDA Average	2.32	0.41	-7.68	-13.63	13.45	3.22	-3.64	-2.08	-1.59
EV/EBITDA High	2.32	0.41	-9.61	-31.52	42.87	5.78	-6.35	-3.1	-4.02
EV/EBITDA Low	2.32	0.41	-6.6	-3.99	7.29	2.01	-1.42	-1.44	-0.95
EV/EBIT Average	2.31	0.4	-7.49	-13.38	13.64	3.25	-3.54	-2.02	-1.55
EV/EBIT High	2.31	0.4	-9.37	-30.94	43.46	5.83	-6.17	-3.02	-3.92
EV/EBIT Low	2.31	0.4	-6.43	-3.91	7.39	2.02	-1.38	-1.4	-0.93
Last Price	- -	- -	12.58	26.78	41.87	25.31	10.06	7.34	6.03
High Price	- -	- -	16.5	75	141.01	41.85	31.55	13.09	14.45
Enterprise Value Average	-188	-48	1,333	3,973	5,739	2,707	2,372	1,117	744
Enterprise Value High	-188	-48	1,667	9,190	18,285	4,855	4,135	1,668	1,881
Enterprise Value Low	-188	-48	1,145	1,163	3,109	1,684	923	773	446

Shares Outstanding	109	109	108	127	131	133	135	137	139
Diluted Weighted Avg Shares	97	97	30	119	133	135	134	136	139
Basic Weighted Avg Shares	97	97	30	119	130	133	134	136	139
Revenue per Share	- -	0.01	0.02	0.56	8.37	11.92	0.29	0.47	0.48
EBITDA per Share	-0.84	-1.2	-5.72	-2.45	3.28	6.33	-4.86	-3.95	-3.38
Operating Income per Share	-0.84	-1.22	-5.86	-2.49	3.24	6.28	-5	-4.05	-3.46
Basic EPS, GAAP	-0.72	-1.19	-5.76	-2.51	4.07	3.89	-4.59	-3.83	-3.16
Basic EPS from Cont Ops	-0.72	-1.2	-5.76	-2.51	4.07	3.89	-4.59	-3.83	-3.16
Diluted EPS, GAAP	-0.72	-1.19	-5.76	-2.51	3.96	3.83	-4.59	-3.83	-3.16
Diluted EPS from Cont Ops	-0.72	-1.2	-5.76	-2.51	3.96	3.83	-4.59	-3.83	-3.16
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.68	-0.97	-4.27	-1.6	-0.37	12.54	-5.81	-3.28	-2.83
Free Cash Flow per Basic Share	-0.71	-1.06	-4.57	-1.66	-0.53	12.03	-5.97	-3.33	-2.86
Cash & Equivalents per Share	1.72	0.9	3.56	5.78	5.4	18.03	11.3	6.61	3.35
Book Value per Share	-0.63	-1.64	3.94	5.63	10.92	15.6	11.8	8.4	5.49
Tangible Book Value per Share	-1.11	-2.13	3.45	5.23	10.53	15.22	11.51	8.22	5.31

Vir Biotechnology, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)